Recent Financial Restructuring Following Endo's emergence from Chapter 11 bankruptcy, the company is in a transitional phase which may present opportunities to offer financial and operational solutions, especially in areas such as risk management, compliance, and restructuring consultancy.

Product Innovation Focus Endo's launch of advanced products like the Spatial Computing Injection Simulator and new branded therapies indicates a commitment to innovation, opening opportunities for partnerships in technology, medical devices, and specialty pharmaceuticals.

Strategic Asset Divestments The sale of assets to Knight Therapeutics suggests Endo is actively streamlining its portfolio, which could create opportunities to engage in asset management, licensing, or partnership negotiations for complementary product lines or technologies.

Market Expansion Activities With recent launches of new treatments and significant financing secured, Endo appears to be expanding its market presence, providing potential sales avenues for medical supplies, marketing services, and distribution partners in North America and beyond.

Technological Adoption Endo’s utilization of diverse tech tools such as SAP, Siemens, and Google Charts indicates a forward-looking approach, suggesting opportunities to offer IT solutions, software integration, and digital health services to support their ongoing innovation efforts.